What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?

被引:22
作者
van Sörnsen de Koste, JR [1 ]
Lagerwaard, FJ [1 ]
Nijssen-Visser, RJ [1 ]
Schuchhard-Schipper, R [1 ]
Joosten, H [1 ]
Senan, S [1 ]
机构
[1] Univ Rotterdam Hosp, Dept Radiat Oncol, NL-3075 EA Rotterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2002年 / 53卷 / 05期
关键词
lymph nodes; mediastinum; lung cancer; mobility; CT scans;
D O I
10.1016/S0360-3016(02)02853-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The mobility of mediastinal nodes was studied on multiple CT scans of the thorax from patients with non-small-cell lung cancer. Patients and Methods: A total of 10 enlarged mediastinal nodes/masses were identified in 8 patients with non-small-cell lung cancer. Nodal locations were classified using the Naruke/ATS-LCSG system, and between 3 and 6 scans were available for each site. The CT data sets were coregistered, and the contoured nodes were automatically projected onto the initial planning CT scan. An encompassing nodal volume (ENV) of all contours of a particular node was manually contoured:on all scans. Individual nodal volumes were expanded in three dimensions to establish additional margins required to encompass the ENV. Results: The mean volume of nodes studied ranged from 0.8 to 23.2 cc. The addition to individual nodes of a margin of 5 rum was found to result in a mean ENV coverage of greater than or equal to95% at all sites. For individual nodes at locations N4R, N5, and N6, however, the coverage ranged from 87.8% to 92.6%. Conclusion: The addition of a margin of 5 mm to individual mediastinal nodes seems to be adequate to account for variations in both contouring and mobility. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:1211 / 1215
页数:5
相关论文
共 21 条
[1]   Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications [J].
Andre, F ;
Grunenwald, D ;
Pignon, JP ;
Dujon, A ;
Pujol, JL ;
Brichon, PY ;
Brouchet, L ;
Quoix, E ;
Westeel, V ;
Le Chevalier, T .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2981-2989
[2]  
ARRIAGADA R, 1997, J CLIN ONCOL, V16, pS446
[3]  
BELDERBOS JS, 2001, INT J RADIAT ONCOL, V51, pS2232
[4]   Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer - an analysis of data generated using 'slow' CT scans [J].
de Koste, JRV ;
Lagerwaard, FJ ;
Schuchhard-Schipper, RH ;
Nijssen-Visser, MRJ ;
Voet, PWJ ;
Oei, SS ;
Senan, S .
RADIOTHERAPY AND ONCOLOGY, 2001, 61 (01) :93-99
[5]   An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer [J].
de Koste, JV ;
Voet, P ;
Dirkx, M ;
van Meerbeeck, J ;
Senan, S .
LUNG CANCER, 2001, 32 (02) :145-153
[6]  
DEBOER JCJ, 2001, INT J RADIAT ONCOL, V49, P859
[7]   AORTIC MOTION - A POTENTIAL PITFALL IN CT IMAGING OF DISSECTION IN THE ASCENDING AORTA [J].
DUVERNOY, O ;
COULDEN, R ;
YTTERBERG, C .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1995, 19 (04) :569-572
[8]   Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J].
Furuse, K ;
Fukuoka, M ;
Kawahara, M ;
Nishikawa, H ;
Takada, Y ;
Kudoh, S ;
Katagami, N ;
Ariyoshi, Y .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2692-2699
[9]   Conformal radiotherapy (CRT) planning for lung cancer: Analysis of intrathoracic organ motion during extreme phases of breathing [J].
Giraud, P ;
De Rycke, Y ;
Dubray, B ;
Helfre, S ;
Voican, D ;
Guo, L ;
Rosenwald, JC ;
Keraudy, K ;
Housset, M ;
Touboul, E ;
Cosset, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :1081-1092
[10]   NORMAL MEDIASTINAL LYMPH-NODES - NUMBER AND SIZE ACCORDING TO AMERICAN-THORACIC-SOCIETY MAPPING [J].
GLAZER, GM ;
GROSS, BH ;
QUINT, LE ;
FRANCIS, IR ;
BOOKSTEIN, FL ;
ORRINGER, MB .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 144 (02) :261-265